Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Jiyin Medical Technology is a Chinese biotechnology company specializing in the development, production, and sales of molecular diagnostic products. Founded in 2015 and headquartered in Guangzhou, the company focuses on providing high-quality solutions for clinical testing in fields such as infectious diseases, oncology, and reproductive health. Their core technology platforms include advanced nucleic acid extraction, real-time PCR, and Next-Generation Sequencing (NGS). The company's product portfolio features a variety of NMPA-certified diagnostic kits, including those for HPV screening, respiratory pathogen detection, and blood-borne virus monitoring. Jiyin Medical operates a large-scale manufacturing facility that adheres to international quality standards like ISO 13485. By integrating R&D with clinical application, the company aims to support precision medicine and improve public health outcomes through early and accurate diagnosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Jiyin Medical Technology.